6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
14D26

Medichem

About Medichem

We are a vertically integrated pharmaceutical company. We specialize in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Our portfolio includes approximately 45 APIs and 20 FDFs, we offer contract development and manufacturing (CDMO) and we are global leaders in chlorhexidine products.  

With over half a century of industry experience, and as a recently certified B Corp, we guarantee the highest standards of quality, operational excellence, and respect for the environment.

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Chemical Development
Contract Manufacturer
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
  • Fructuós Gelabert, 6-8, Conata II Building, 5th floor, 08970, Sant Joan Despi, Barcelona, Spain

Products from Medichem (58)

  • SUGAMMADEX SODIUM FDF

    Product SUGAMMADEX SODIUM FDF

    SOLUTION FOR INJECTION ANESTHESIA FDF
  • PRUCALOPRIDE succinate FDF

    Product PRUCALOPRIDE succinate FDF

    film-coated tablets - chronic constipation FDF
  • DAPTOMYCIN FDF

    Product DAPTOMYCIN FDF

    Medichem S.A. offers wide range of finished dosage forms for licencing which includes Daptomycin. Indication: Antibiotic. Pharmaceutical form: Powder for solution for injection or infusion in glass vial. Strength: 350 mg, 500 mg. Dossier status: EU filed.
  • RIVAROXABAN FDF

    Product RIVAROXABAN FDF

    Medichem S.A. offers wide range of pharmaceutical APIs and FDF which includes Rivaroxaban. Indication: Antithrombotic. Contact us for more information.
  • SUNITINIB MALATE FDF

    Product SUNITINIB MALATE FDF

    Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sunitinib Malate. Indication: Kidney Cancer/ GIT Stromal Tumors. Pharmaceutical form: Capsules. Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg. Dossier status: EU filed.
  • APIXABAN FDF

    Product APIXABAN FDF

    Medichem S.A. offers wide range of finished dosage forms for licencing which includes Apixaban. Indication: Antithrombotic. Pharmaceutical form: Film-coated tablets. Strength: 2.5 mg, 5 mg. Dossier status: EU under preparation, US filed (exclusive in the US).
  • TOBRAMYCIN FDF

    Product TOBRAMYCIN FDF

    Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Tobramycin. Indication: Cystic Fibrosis. Pharmaceutical form: Solution for inhalation in plastic ampoule blow-fill-seal. Strength: 300 mg/5 ml. Dossier status: EU/BR approved, AU filed, US under prepar...
  • THALIDOMIDE FDF
  • CAPTOPRIL FDF

    Product CAPTOPRIL FDF

    Medichem S.A. offers a wide range of finished dosage forms for licencing which includes CAPTOPRIL. Indication: Hypertension Pharmaceutical form: Tablets. Strength: 12.5, 25, 50 and 100 mg. Dossier status: Filed ANDA
  • SODIUM OXYBATE FDF

    Product SODIUM OXYBATE FDF

    Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sodium Oxybate. Indication: Narcolepsy. Pharmaceutical form: Oral Solution in bottle. Strength: 300 mg/ml. Dossier status: EU approved.
  • Edavarone FDF

    Product Edavarone FDF

    amyotrophic lateral sclerosis (ALS) 
  • LIFITEGRAST FDF

    Product LIFITEGRAST FDF

    Medichem S.A. offers wide range of pharmaceutical finished dosage forms for licencing which son includes LIFITEGRAST. Indication: Ophtalmic solution. Pharmaceutical form: 5% . 

Medichem Resources (2)